EyePoint Pharmaceuticals Inc. sell StockNews.com
Start price
21.09.24
/
50%
€8.17
Target price
21.09.25
-
Performance (%)
39.63%
End price
22.09.25
€11.41
Summary
This prediction ended on 22.09.25 with a price of €11.41. The price for EyePoint Pharmaceuticals Inc. massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 7.851% | 7.851% | 73.353% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by StockNews_com for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.04
04.03.23
04.03.23
-
04.03.24
04.03.24
669.74%
05.03.24
05.03.24
